Literature DB >> 21922315

Chiari and Syringomyelia Consortium: a model of multidisciplinary and sharing path for rare diseases.

Palma Ciaramitaro1, Simone Baldovino, Dario Roccatello, Edo Bottacchi, Giuliano Faccani.   

Abstract

Piemonte and Valle d'Aosta Interregional Network for Rare Diseases (RD) is a model of "diffuse" network; it involves all the health system specialists devoted to the diagnosis, the therapy and the follow-up of a RD. The Consortium is a multidisciplinary team operating throughout the Region composed of volunteer Physicians and Biologists that promotes periodical meetings to develop shared protocols. In 2008 the Specialist-Technical Committee for the Interregional RD Network approved the set up of the "Chiari and Syringomyelia Consortium" (CSC) with two specific objectives: to identify the shared diagnostic criteria and to develop the interdisciplinary diagnostic-therapeutic-assistance path (DTAP) to be used interregionally. Other objectives are: to define the prevalence of the pathologies (both symptomatic and asymptomatic, both in adults and children) and to improve collaboration between the patient Associations and the Physicians.

Entities:  

Mesh:

Year:  2011        PMID: 21922315     DOI: 10.1007/s10072-011-0725-y

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  3 in total

Review 1.  Piedmont and Aosta Valley inter-regional network in the context of the Italian National Network for rare diseases.

Authors:  Simone Baldovino; Elisa Menegatti; Vittorio Modena; Maria Maspoli; Flavia Avanzi; Dario Roccatello
Journal:  Blood Transfus       Date:  2014-04       Impact factor: 3.443

2.  Clinical diagnosis-part I: what is really caused by Chiari I.

Authors:  Palma Ciaramitaro; Marilena Ferraris; Fulvio Massaro; Diego Garbossa
Journal:  Childs Nerv Syst       Date:  2019-06-03       Impact factor: 1.475

3.  Diagnosis and treatment of Chiari malformation and syringomyelia in adults: international consensus document.

Authors:  Palma Ciaramitaro; Luca Massimi; Alessandro Bertuccio; Alessandra Solari; Mariangela Farinotti; Paola Peretta; Veronica Saletti; Luisa Chiapparini; Andrea Barbanera; Diego Garbossa; Paolo Bolognese; Andrew Brodbelt; Carlo Celada; Dario Cocito; Marcella Curone; Grazia Devigili; Alessandra Erbetta; Marilena Ferraris; Marika Furlanetto; Mado Gilanton; George Jallo; Marieta Karadjova; Jorg Klekamp; Fulvio Massaro; Sylvia Morar; Fabrice Parker; Paolo Perrini; Maria Antonia Poca; Juan Sahuquillo; Marcus Stoodley; Giuseppe Talamonti; Fabio Triulzi; Maria Consuelo Valentini; Massimiliano Visocchi; Laura Valentini
Journal:  Neurol Sci       Date:  2021-06-15       Impact factor: 3.307

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.